BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38806204)

  • 1. As needed ICS/formoterol: not all of Europe is equal.
    Bush A; Randerath W; Roche N
    Eur Respir J; 2024 May; 63(5):. PubMed ID: 38806204
    [No Abstract]   [Full Text] [Related]  

  • 2. The evidence base for ICS/formoterol maintenance and reliever therapy in severe asthma.
    Beasley R; Noble J; Weatherall M
    Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38901890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ICS/formoterol maintenance and reliever therapy: how far beyond asthma?
    Beasley R; Bruce P; Hatter L
    Thorax; 2023 May; 78(5):430-431. PubMed ID: 36863775
    [No Abstract]   [Full Text] [Related]  

  • 4. As-needed Dual Inhaled Corticosteroid-Formoterol in Mild Asthma: Scientific Evidence.
    Beasley R; Ferreira DS; Papi A
    Arch Bronconeumol; 2024 Apr; 60(4):197-199. PubMed ID: 38326118
    [No Abstract]   [Full Text] [Related]  

  • 5. The ICS/Formoterol Reliever Therapy Regimen in Asthma: A Review.
    Beasley R; Bruce P; Houghton C; Hatter L
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):762-772.e1. PubMed ID: 36639054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Satisfaction with single maintenance and reliever therapy or as-needed combined inhaled corticosteroid-formoterol in adults with asthma.
    LaCava AF; Gleeson PK; Apter AJ
    J Allergy Clin Immunol Pract; 2023 Mar; 11(3):952-954.e1. PubMed ID: 36470520
    [No Abstract]   [Full Text] [Related]  

  • 7. A Call for the United States to Accelerate the Implementation of Reliever Combination Inhaled Corticosteroid-Formoterol Inhalers in Asthma.
    Krings JG; Gerald JK; Blake KV; Krishnan JA; Reddel HK; Bacharier LB; Dixon AE; Sumino K; Gerald LB; Brownson RC; Persell SD; Clemens CJ; Hiller KM; Castro M; Martinez FD
    Am J Respir Crit Care Med; 2023 Feb; 207(4):390-405. PubMed ID: 36538711
    [No Abstract]   [Full Text] [Related]  

  • 8. Trends in prescribing as-needed inhaled corticosteroid (ICS)-Formoterol for patients with asthma.
    Li J; Price KR; Weeda ER; Garner SS
    Respir Med; 2023 Feb; 207():107096. PubMed ID: 36574912
    [No Abstract]   [Full Text] [Related]  

  • 9. The Role of ICS-Containing Rescue Therapy Versus SABA Alone in Asthma Management Today.
    Krings JG; Beasley R
    J Allergy Clin Immunol Pract; 2024 Apr; 12(4):870-879. PubMed ID: 38237858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and Effectiveness of As-Needed Formoterol in Asthma Patients Taking Inhaled Corticosteroid (ICS)-Formoterol or ICS-Salmeterol Maintenance Therapy.
    Reddel HK; Brusselle G; Lamarca R; Gustafson P; Anderson GP; Jorup C
    J Allergy Clin Immunol Pract; 2023 Jul; 11(7):2104-2114.e3. PubMed ID: 37054881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Major change in asthma management].
    Akhmetova L; Cucchiara R; Charbonnier F; Sommer J; Salamun J
    Rev Med Suisse; 2022 Sep; 18(797):1788-1791. PubMed ID: 36170130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Versus Old: The Impact of Changing Patterns of Inhaled Corticosteroid Prescribing and Dosing Regimens in Asthma Management.
    Singh D; Garcia G; Maneechotesuwan K; Daley-Yates P; Irusen E; Aggarwal B; Boucot I; Berend N
    Adv Ther; 2022 May; 39(5):1895-1914. PubMed ID: 35284999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving asthma control with ICS/LABA: A review of strategies for asthma management and prevention.
    Aalbers R; Vogelmeier C; Kuna P
    Respir Med; 2016 Feb; 111():1-7. PubMed ID: 26614594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Budesonide/formoterol maintenance and reliever therapy in Asian patients (aged ≥16 years) with asthma: a sub-analysis of the COSMOS study.
    Vogelmeier C; Naya I; Ekelund J
    Clin Drug Investig; 2012 Jul; 32(7):439-49. PubMed ID: 22607479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjustable maintenance dosing with budesonide/formoterol reduces asthma exacerbations compared with traditional fixed dosing: a five-month multicentre Canadian study.
    FitzGerald JM; Sears MR; Boulet LP; Becker AB; McIvor AR; Ernst P; Smiljanic-Georgijev NM; Lee JS;
    Can Respir J; 2003; 10(8):427-34. PubMed ID: 14679407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A simple and effective evidence-based approach to asthma management: ICS-formoterol reliever therapy.
    Levy ML; Beasley R; Bostock B; Capstick TG; Crooks MG; Fleming L; Freeman D; Marsh V; Rupani H; Whittamore A; Barnes PJ; Bush A
    Br J Gen Pract; 2024 Feb; 74(739):86-89. PubMed ID: 38272684
    [No Abstract]   [Full Text] [Related]  

  • 17. [From a trail to an official path: new recommendations for the treatment of mild asthma].
    Lommatzsch M
    Dtsch Med Wochenschr; 2020 Jun; 145(11):767-771. PubMed ID: 32492747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The management of mild asthma.
    O'Byrne PM; Reddel HK; Beasley R
    Eur Respir J; 2021 Apr; 57(4):. PubMed ID: 33093120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Self-titration of inhaled corticosteroid and β
    Baggott C; Hardy J; Sparks J; Holliday M; Hall D; Vohlidkova A; Hancox RJ; Weatherall M; Fingleton J; Beasley R;
    Eur Respir J; 2020 Oct; 56(4):. PubMed ID: 32444401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma.
    Beasley R; Braithwaite I; Semprini A; Kearns C; Weatherall M; Harrison TW; Papi A; Pavord ID
    Eur Respir J; 2020 Jan; 55(1):. PubMed ID: 31919194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.